Valuation GSK plc

Equities

Market Closed - London S.E. Other stock markets 11:35:18 2025-07-15 am EDT			5-day change	1st Jan Change
1,402.50 ^GBX	-1.54%		-0.81%	+4.16%

12:33pm	FTSE 100 retreats from record high as tariff worries resurface	RE
12:20pm	European Equities Close Lower in Tuesday Trading; EU Targets Industrial Goods in Tariff Row	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	66,801	80,458	58,381	59,112	54,944	56,746	-	-
Change	-	20.44%	-27.44%	1.25%	-7.05%	3.28%	-	-
Enterprise Value (EV) ¹	87,581	100,296	75,578	74,152	68,039	70,049	67,390	64,381
Change	-	14.52%	-24.65%	-1.89%	-8.24%	2.95%	-3.8%	-4.46%
P/E ratio	11.8x	18.6x	3.93x	11.9x	21.3x	9.89x	8.8x	8.3x
PBR	4.58x	5.34x	5.47x	4.4x	4.02x	3.89x	3.22x	2.71x
PEG	-	-0.8x	0x	-0.2x	-0.4x	0x	0.7x	1.37x
Capitalization / Revenue	1.96x	2.36x	1.99x	1.95x	1.75x	1.77x	1.68x	1.61x
EV / Revenue	2.57x	2.94x	2.58x	2.45x	2.17x	2.19x	2x	1.82x
EV / EBITDA	9.19x	8.85x	7.23x	6.37x	6.36x	6.48x	5.75x	5.19x
EV / EBIT	9.83x	11.4x	9.27x	8.44x	7.44x	7.43x	6.55x	5.82x
EV / FCF	16.2x	22.6x	12.1x	13.6x	13x	13.7x	10.2x	9.02x
FCF Yield	6.17%	4.42%	8.28%	7.36%	7.67%	7.29%	9.84%	11.1%
Dividend per Share ²	1	1	0.6125	0.58	0.61	0.6506	0.6908	0.7349
Rate of return	5.96%	4.98%	4.26%	4%	4.53%	4.57%	4.85%	5.16%
EPS ²	1.426	1.082	3.662	1.216	0.632	1.44	1.618	1.716
Distribution rate	70.1%	92.4%	16.7%	47.7%	96.5%	45.2%	42.7%	42.8%
Net sales ¹	34,099	34,114	29,324	30,328	31,376	31,999	33,751	35,302
EBITDA ¹	9,530	11,330	10,449	11,635	10,693	10,812	11,728	12,402
EBIT ¹	8,906	8,806	8,151	8,786	9,148	9,424	10,288	11,054
Net income ¹	5,749	4,385	14,956	4,928	2,575	5,709	6,427	6,837
Net Debt ¹	20,780	19,838	17,197	15,040	13,095	13,303	10,643	7,635
Reference price ²	16.78	20.08	14.38	14.50	13.46	14.24	14.24	14.24
Nbr of stocks (in thousands)	3,982,185	4,006,383	4,060,999	4,076,145	4,080,519	4,046,081	-	-
Announcement Date	2/3/21	2/9/22	2/1/23	1/31/24	2/5/25	-	-	-

¹GBP in Million²GBP

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GSK PLC	10.02x	2.22x	6.65x	4.56%	77.51B
ELI LILLY AND COMPANY	37.59x	12.4x	28.24x	0.74%	718B
JOHNSON & JOHNSON	15.03x	4.2x	11.56x	3.35%	377B
ABBVIE INC.	27.31x	6.56x	13.72x	3.42%	338B
NOVO NORDISK A/S	17.01x	6.14x	12.26x	2.97%	308B
ROCHE HOLDING AG	14.2x	3.5x	8.59x	3.83%	259B
NOVARTIS AG	17.18x	4.63x	11.23x	3.25%	237B
ASTRAZENECA PLC	22.67x	4.21x	12.19x	2.24%	222B
MERCK & CO., INC.	10.72x	3.48x	7.51x	3.85%	210B
AMGEN INC.	22.71x	5.81x	11.21x	3.23%	160B
Average	19.44x	5.31x	12.32x	3.14%	290.75B
Weighted average by Cap.	22.90x	6.66x	15.31x	2.68%